WO2003020708A1 - Produits intermediaires de zosinamide et synthese y relative - Google Patents
Produits intermediaires de zosinamide et synthese y relative Download PDFInfo
- Publication number
- WO2003020708A1 WO2003020708A1 PCT/US2002/027593 US0227593W WO03020708A1 WO 2003020708 A1 WO2003020708 A1 WO 2003020708A1 US 0227593 W US0227593 W US 0227593W WO 03020708 A1 WO03020708 A1 WO 03020708A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bos
- mixture
- benzisoxazole
- crystalline
- process according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
Definitions
- the second method described in literature for zomsamide preparation includes the preparation of BOA starting f om 4-hydroxy-coumarin, followed by the sulfonation reaction of BOA to BOS.
- the sulfonation reaction of the zonisamide intermediate i.e., BOA
- the reagent chlorosulfonic acid is used in a large excess and it is also the reaction solvent.
- the reactions of this synthetic method are shown in scheme 2:
- the present invention provides a novel crystal form of BOS-Na Form ⁇ , characterized by an X-Ray Powder Diffraction (XRD) having the main peaks at about 5.3, 16.6, 21.3 and 26.7 ⁇ 0.2 degrees two theta.
- XRD X-Ray Powder Diffraction
- the present invention provides a novel crystal form of BOS-Na Form HI, characterized by a Furier Transform Infra Red Spectroscopy (FTIR) spectrum having the most characteristic peaks at about 3604, 1065, 812 and 696 cm '1 .
- FTIR Furier Transform Infra Red Spectroscopy
- Fig. 15 depicts the Furier Transform Infra Red Spectroscopy (FTIR) spectrum of BOS-Ba novel Form I.
- FTIR Furier Transform Infra Red Spectroscopy
- the sulfonation process for the Ac 2 O/H SO involves a reaction that is performed in polar and non-polar solvents.
- the polar solvents include ethylacetate, ethylcellosolve, methylcellosolve, dichloroethane, dichloromethane, chloroform or mixture thereof and the like.
- the non-polar solvents include toluene, heptane, hexanes, alkanes or mixtures thereof and the like.
- Example 4 Preparation of BOS-Na: CISO3H in dichloroethane In a 100 mL three necked flask, equipped with thermometer, condenser and mechanical stirrer was charged dichloroethane (25 mL), 2.5 mL ClSO 3 H (1.3 eq.), and BOA (5 grams). The reaction mixture was heated at reflux for 1.5 hours.
- BOS-Na monohydrate novel form I is characterized by the following X-Ray Diffraction main peaks at about 5.0, 15.7, 16.5, 17.3, 18.6, 19.1, 19.7, 21.5, 22.8, 23.2, 23.5 and 24.3 ⁇ 0.2 degrees two theta.
- Water content measured by Karl-Fischer (KF) method is in agreement with TGA weight loss step and is about 7%. This water content is coincident with the expected water content of monohydrate.
- DTG DTG profile of BOS-Ba novel form I is characterized by an endothermic peak at about 200°C. A weight loss step of about 3.5% is observed in this temperature range.
- reaction mixture was cooled to room temperature and ice was added.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002458905A CA2458905A1 (fr) | 2001-08-30 | 2002-08-29 | Produits intermediaires de zosinamide et synthese y relative |
IL15823902A IL158239A0 (en) | 2001-08-30 | 2002-08-29 | Zonisamide intermediate and synthesis |
JP2003524979A JP2005506980A (ja) | 2001-08-30 | 2002-08-29 | ゾニスアミド中間体及び合成 |
EP02768748A EP1430037A4 (fr) | 2001-08-30 | 2002-08-29 | Produits intermediaires de zosinamide et synthese y relative |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31610901P | 2001-08-30 | 2001-08-30 | |
US60/316,109 | 2001-08-30 | ||
US34443901P | 2001-10-24 | 2001-10-24 | |
US60/344,439 | 2001-10-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003020708A1 true WO2003020708A1 (fr) | 2003-03-13 |
Family
ID=26980239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/027593 WO2003020708A1 (fr) | 2001-08-30 | 2002-08-29 | Produits intermediaires de zosinamide et synthese y relative |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1430037A4 (fr) |
JP (1) | JP2005506980A (fr) |
CA (1) | CA2458905A1 (fr) |
IL (1) | IL158239A0 (fr) |
WO (1) | WO2003020708A1 (fr) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1472236A1 (fr) * | 2002-02-22 | 2004-11-03 | Teva Pharmaceutical Industries Ltd. | Procede servant a la preparation de chlorure de benzisoxazole methane sulfonyle et a son amidation pour former un zonisamide |
WO2005030738A1 (fr) * | 2003-09-29 | 2005-04-07 | Suven Life Sciences Limited | Procede ameliore de fabrication d'intermediaires utilises pour l'obtention de zonisamide |
US6900333B2 (en) | 2003-01-13 | 2005-05-31 | Dainippon Pharmaceutical Co., Ltd. | Process for the preparation of 1, 2-dichlorethane free crystals of zonisamide |
US7375233B2 (en) | 2005-12-16 | 2008-05-20 | Apotex Pharmachem Inc. | Process for the preparation of zonisamide and the intermediates thereof |
US7745471B2 (en) | 2004-06-18 | 2010-06-29 | Chemagis Ltd. | Derivatives of 1,2-benzisoxazole-3-methane sulfonic acid as novel intermediates for the synthesis of zonisamide |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL376216A1 (en) * | 2003-01-10 | 2005-12-27 | Dipharma S.P.A. | A process for the preparation of benzo[d]isoxazol-3-yl-methanesulfonic acid and the intermediates thereof |
EP1935888A4 (fr) * | 2005-09-16 | 2011-07-13 | Dainippon Sumitomo Pharma Co | Procédé de sulfonation de l' acide 1,2-benzisoxazole-3-acétique |
WO2018004994A1 (fr) | 2016-07-01 | 2018-01-04 | Res Usa, Llc | Réacteur à membrane à lit fluidisé |
WO2018004993A1 (fr) | 2016-07-01 | 2018-01-04 | Res Usa, Llc | Réduction des émissions de gaz à effet de serre |
WO2018004992A1 (fr) | 2016-07-01 | 2018-01-04 | Res Usa, Llc | Conversion de méthane en diméthyléther |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5377057A (en) * | 1976-12-16 | 1978-07-08 | Dainippon Pharmaceut Co Ltd | 1,2-benxisoxazole derivatives |
US4172896A (en) * | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
JPS54163570A (en) * | 1978-06-12 | 1979-12-26 | Dainippon Pharmaceutical Co | Benzooxazole derivative |
JPS54163823A (en) * | 1978-06-12 | 1979-12-26 | Dainippon Pharmaceutical Co | Antiiepileptic agent based on 33sulphamoylmethyll 1*22benzisoxazole |
FR2428033A1 (fr) * | 1978-06-09 | 1980-01-04 | Dainippon Pharmaceutical Co | Nouveaux derives heterocycliques de methanesulfonamide utiles notamment comme anticonvulsivants et leur procede de preparation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002070495A1 (fr) * | 2001-03-02 | 2002-09-12 | Teva Pharmaceutical Industries Ltd. | Procede de preparation d'acide 1,2-benzisoxazole-3-acetique |
-
2002
- 2002-08-29 EP EP02768748A patent/EP1430037A4/fr not_active Withdrawn
- 2002-08-29 CA CA002458905A patent/CA2458905A1/fr not_active Abandoned
- 2002-08-29 WO PCT/US2002/027593 patent/WO2003020708A1/fr not_active Application Discontinuation
- 2002-08-29 IL IL15823902A patent/IL158239A0/xx unknown
- 2002-08-29 JP JP2003524979A patent/JP2005506980A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5377057A (en) * | 1976-12-16 | 1978-07-08 | Dainippon Pharmaceut Co Ltd | 1,2-benxisoxazole derivatives |
US4172896A (en) * | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
FR2428033A1 (fr) * | 1978-06-09 | 1980-01-04 | Dainippon Pharmaceutical Co | Nouveaux derives heterocycliques de methanesulfonamide utiles notamment comme anticonvulsivants et leur procede de preparation |
JPS54163570A (en) * | 1978-06-12 | 1979-12-26 | Dainippon Pharmaceutical Co | Benzooxazole derivative |
JPS54163823A (en) * | 1978-06-12 | 1979-12-26 | Dainippon Pharmaceutical Co | Antiiepileptic agent based on 33sulphamoylmethyll 1*22benzisoxazole |
Non-Patent Citations (2)
Title |
---|
See also references of EP1430037A4 * |
UNO ET AL.: "Studies on 3-substituted 1,2-benzisoxazole derivatives. VII. Catalytic reduction of 3-sulfamoylmethyl-1,2-benzisoxazole and reactions of the resulting products", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 30, no. 1, 1981, pages 333 - 335, XP002959509 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1472236A1 (fr) * | 2002-02-22 | 2004-11-03 | Teva Pharmaceutical Industries Ltd. | Procede servant a la preparation de chlorure de benzisoxazole methane sulfonyle et a son amidation pour former un zonisamide |
EP1472236A4 (fr) * | 2002-02-22 | 2006-04-19 | Teva Pharma | Procede servant a la preparation de chlorure de benzisoxazole methane sulfonyle et a son amidation pour former un zonisamide |
US6900333B2 (en) | 2003-01-13 | 2005-05-31 | Dainippon Pharmaceutical Co., Ltd. | Process for the preparation of 1, 2-dichlorethane free crystals of zonisamide |
WO2005030738A1 (fr) * | 2003-09-29 | 2005-04-07 | Suven Life Sciences Limited | Procede ameliore de fabrication d'intermediaires utilises pour l'obtention de zonisamide |
US7745471B2 (en) | 2004-06-18 | 2010-06-29 | Chemagis Ltd. | Derivatives of 1,2-benzisoxazole-3-methane sulfonic acid as novel intermediates for the synthesis of zonisamide |
US7375233B2 (en) | 2005-12-16 | 2008-05-20 | Apotex Pharmachem Inc. | Process for the preparation of zonisamide and the intermediates thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2005506980A (ja) | 2005-03-10 |
CA2458905A1 (fr) | 2003-03-13 |
IL158239A0 (en) | 2004-05-12 |
EP1430037A1 (fr) | 2004-06-23 |
EP1430037A4 (fr) | 2004-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20060069267A1 (en) | Novel sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms | |
US8759525B2 (en) | Process and intermediates for preparing integrase inhibitors | |
US6841683B2 (en) | Sulfonation method for zonisamide intermediate in zonisamide synthesis and their novel crystal forms | |
EA022099B1 (ru) | Способы и интермедиаты для получения ингибиторов интегразы | |
EP1430037A1 (fr) | Produits intermediaires de zosinamide et synthese y relative | |
TW201904975A (zh) | 1,3-苯并二氧雜環戊烯雜環化合物之製備方法 | |
JPH0469628B2 (fr) | ||
CN101501011A (zh) | 制备3,4-二氢-1,2,3-氧杂噻嗪-4-酮-2,2-二氧化物化合物的钾盐的方法 | |
EP1375487B1 (fr) | Procede de production d'un compose d'acide quinoline-3-carboxylique | |
Papadopoulos | Reactions of pyrrole with isocyanates. Preparation and reactions of N-ethoxy-carbonylpyrrole-2-carboxamide and pyrrole-1, 2-dicarboximide | |
US20060142595A1 (en) | Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI | |
CA2545119A1 (fr) | Procede de fabrication de zonisamide | |
EP0149229B1 (fr) | 3-(Gamma-chloropropyl)-6-fluor-1,2-benzisoxazole, procédé pour le préparer et son utilisation comme intermédiaire | |
CN111153866A (zh) | 帕瑞昔布钠双取代杂质及其制备方法和应用 | |
CN113227113A (zh) | 环氧化催化剂的改进合成 | |
JPS6140661B2 (fr) | ||
CZ2002146A3 (cs) | Způsob přípravy 2-methoxy-4-(N-terc-butylaminokarbonyl)-benzensulfonylchloridu | |
RU2032679C1 (ru) | Производные бензатиазинов | |
SU615859A3 (ru) | Способ получени 6-дезокси-6-азидо-7,8-дигидроизоморфина или 6-дезокси-6-азидо-14-окси-7,8-дигидроизоморфина или их 3-алкиокси- или 3-алканоилокси-производных или их солей | |
CH647525A5 (fr) | Solvats cristallins du 7-phenoxyacetamido-3-hydroxy-3-cephem-4-carboxylate de 4'-nitrobenzyle et de son sulfoxyde, et leur preparation. | |
CN114195694A (zh) | 一种吡咯化合物的制备方法 | |
CN115925589A (zh) | 一种脂肪族亚磺酸钙盐及其制备方法 | |
CN115925588A (zh) | 一种脂肪族亚磺酸钠盐的制备方法 | |
CA2512791A1 (fr) | Procede de preparation d'acide methanesulfonique benzo[d]isoxazol-3-yle et ses intermediaires | |
JPH09169754A (ja) | テトラヒドロフラン誘導体の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 158239 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2458905 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003524979 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002768748 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002768748 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002768748 Country of ref document: EP |